11 development-"https:"-"https:"-"https:"-"https:"-"https:"-"Indiana-University" Fellowship positions at UCL
Sort by
Refine Your Search
-
community of over 500 staff and more than 300 PhD students engaged in cutting edge research and collaboration. Further information can be found on our website https://www.ucl.ac.uk/biosciences We are seeking
-
, dependent on NHS contract and/or stage of clinical training. As well as the exciting opportunities this role presents, we also offer some great benefits; visit https://www.ucl.ac.uk/work-at-ucl/reward
-
rare opportunity to work across the complete development chain of a medical device: from designing the sensors, through the readout electronics and data analysis, to integrating the system with
-
molecular diagnostics, infectious disease epidemiology, research training, and investigator mentorship. SPHERE-AFRICA, led by Prof Peter Nyasulu (Stellenbosch University, South Africa), aims to
-
community of over 500 staff and more than 300 PhD students engaged in cutting edge research and collaboration. Further information can be found on our website https://www.ucl.ac.uk/biosciences This is an
-
biomedicine, including Professor Vijay Chudasama’s group in UCL Chemistry. The London Centre for Nanotechnology (LCN) is an interdisciplinary enterprise between University College London, King’s College
-
EU grant funded project and will be involved in the development AI supported diagnostic tools and assessing off-the-shelf AI-assisted technology for ophthalmic analysis and data capture, in close
-
informed by world-class research. IGH aims to support the development of robust solutions to aspects of the world’s major global health challenges through scholarly outputs, education, public engagement
-
Jepson laboratory and in collaboration with Dr Jenna Carpenter, you will contribute to research aimed at informing the development of a potential gene therapy for a severe neurodevelopmental disorder
-
development of non-viral approaches, using mRNA and non-viral gene therapy, as potential treatment options for two genes of interest MYO7A and GUCY2D-retinopathy. The Post Doctoral Fellow will use a